在此前遭到美国食品药品监督管理局(FDA)反对后，Moderna(MRNA.US)基于mRNA技术开发的流感疫苗mFLUSIVA终于获批上市，这对该公司而言无疑是一项重大胜利。 Moderna在一份声明中表示，mFLUSIVA获批用于50岁及以上成人。其中，针对50至64岁人群获得传统完全批准，而针对65岁及以上人群则获得加速批准。这是美国首款获批的mRNA流感疫苗，也是Moderna在全球范围内 ...

The Food and Drug Administration has approved a new flu vaccine made with the same mRNA technology that was used for the COVID-19 shots.

The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including cancer, according to a new review published in The Lancet Tuesday.

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we ...

Researchers at the University of Cologne and University Hospital Cologne have determined that the novel mRNA-based COVID-19 vaccines not only induce acquired immune responses such as antibody ...

Add Yahoo as a preferred source to see more of our stories on Google. With a little help, your immune cells can be potent tumor killers. Steve Gschmeissner/Science Photo Library via Getty Images The ...

Vaccines using mRNA technology weren’t immune to the latest round of federal research cuts. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he’s pulling the plug on ...

WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...

The messenger RNA (mRNA) COVID-19 vaccines were game changing during the course of the pandemic; now another benefit is emerging—the same vaccines are improving how long people with cancer survive ...

The claim stemmed from two recent cohort studies, one from South Korea and one from Italy.